Welcoming participants to the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place this week Chicago, ASCO CEO Clifford Hudis, MD, acknowledged the detrimental effects of ...

Chemotherapy plus immunotherapy maintenance regimen extends progression-free and overall survival for patients with extensive-stage small-cell lung cancer.

Researchers use CRISPR-Cas9 gene-editing tool on tumor cells grown in mice to better model how tumors that initially respond to chemotherapy become resistant.

Accurate classification of breast cancer receptor status can help guide treatment decisions, making more patients eligible for HER2 targeted therapies.

University of Colorado Cancer Center member Al Barqawi, MD, talks about the latest developments in the disease. May 28, 2025 • By Greg Glasgow at the University of Colorado Cancer Center ...

Chemotherapy doesn’t just kill cancer cells. It also affects the microbes in the digestive tract. Researchers at UC San Francisco have discovered that some gut bacteria can reduce the side effects of ...

Adding inavolisib to palbociclib and fulvestrant improved overall survival for people with previously treated PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer.

Maybe it was already there when he was at Disney World. Sitting in his office on a late-winter morning, wearing jeans and a hooded sweatshirt adorned on the front with a teddy bear in a business suit, ...

To make a bigger difference, you can make more noise. “Contact your state,” Lakdawala said. “This is what I’ve realized: it’s really up to the states.” Contact your governor and state or local ...

As part of a cutting-edge study aimed at restoring fertility in young male cancer survivors, a 26-year-old man who had childhood cancer has received the first known transplant of sperm-producing stem ...

Recruiting and screening individuals for clinical trials is time-consuming and can account for to up to one third of trial costs. But researchers have found that artificial intelligence (AI) could ...

A custom-made messenger RNA (mRNA) vaccine plus an immune checkpoint inhibitor appears to reduce the risk of pancreatic cancer recurrence for at least three years after surgery, according to results ...